Home News
News


MCS starts an international collaboration to bring new light on the role of melatonin in various diseases

The MCS (Medicinal Chemistry & Synthesis) group from IQAC has started a collaboration with the Functional Pharmacology and Pathophysiology of Membrane Receptors group from the Institute Cochin in Paris. Directed by Ralf Jockers, the group is a world leader in the study of melatonin receptors, a hormone that has been linked to certain metabolic and neurodegenerative diseases.
This four-year project aims to characterize the interaction between the cell surface and the intracellular melatonin receptors. The collaboration contemplates the development of innovative pharmacological tools based on photoregulated ligands - one of the MCS specialties - that provide new data on the role of melatonin in different diseases. The main objective is to redirect the design of drugs towards a better therapeutic efficacy.
 

Recent articles

Allosteric control of an asymmetric transduction in a G protein-coupled receptor heterodimer


Junke Liu, Zongyong Zhang, David Moreno-Delgado, James AR Dalton, Xavier Rovira, Ana Trapero, Cyril Goudet, Amadeu Llebaria, Jesús Giraldo, Qilin Yuan, Philippe Rondard, Siluo Huang, Jianfeng Liu and Jean-Philippe Pin



Design of Hückel–Möbius Topological Switches with High Nonlinear Optical Properties

Miquel Torrent-Sucarrat, Sara Navarro, Enrique Marcos, Josep M. Anglada and Josep M. Luis



 


Page 3 of 49